Container Top
Homes   Jobs   Cars   Shopping
Search

Events Calendar

EVENT SEARCH:

In This Section


Most Read Stories


Blogs:


Pets:
Cat-loving chihuahua suckles seven abandoned kittens

The Heldenfiles:
Friday Night Notebook

Patrick McManamon:
For your Saturday entertainment …

Akron Zips:
Two blowouts, one night

Tribe Matters:
Seven players added to Tribe’s 40-man roster

Cleveland Browns:
Holmgren expresses interest in Browns position

Kent State Sports:
Singletary update

Cleveland Cavaliers:
Gameblog: Cavs at Indiana Pacers – Here’s to LBJ and Free Throws

Buckeye Blogging:
OSU – Michigan college football rivals meet in Baghdad

Varsity Letters:
Bowling season starts today

All Da King's Men:
Headed For Disaster

Blog of Mass Destruction:
Akron Law Café:
Federal Judge Declares DOMA Unconstitutional

See Jane Style:
Vintage Chic

Car Chase:
TIME TO GET YOUR COLLECTOR CARS WINTERIZED

Let's Talk Real Estate:
Silverdome Potentially SOLD!

Ohio Travels with Betty:
George is looking for a Thanksgiving buffet in Akron.

Sound Check:
Steely Dan Plays "The Royal Scam" at E.J. Thomas Hall

HRLite House:
Colloquium at University of Akron

Akron Gamer:
Nintendo's Mario endures even as games come and go

Enrollment in heart-disease study halted

Officials investigate whether participants informed of risk in the largest alternative medicine program

The largest alternative medicine study the government has ever launched has stopped enrolling people while officials investigate whether participants were fully informed of the risks and are being adequately protected, the Associated Press has learned.

More than 1,500 heart-attack survivors are involved in the research, which tests a controversial treatment called chelation. It is mainly used to treat lead poisoning.

At least two people have died, although the Miami doctor leading the study said the deaths were not a direct result of the treatments. He said he doesn't know exactly how many deaths have occurred.

He also acknowledged that some doctors who had been involved in the study have been disciplined by state boards or have criminal records and have been asked to drop out.

''We think we have a safe and ethical trial and we're protecting our patients,'' said the leader, Dr. Gervasio Lamas of the University of Miami.

Federal officials confirmed their probe of the $30 million study Thursday. Those directing the research, conducted at 100 sites around the United States and Canada, voluntarily stopped enrolling patients earlier this month, after the investigation was launched.

The research was designed to test high doses of vitamin and mineral supplements and chelation, which has not been proved effective for heart disease. Chelation involves intravenous doses of a drug, in this case disodium EDTA, that proponents claim will bind to calcium built up in artery walls and help flush it from the body.

Conventional treatments for heart disease include medicines, surgery and artery-clearing angioplasty.

When the study was approved in 2002, federal officials said many heart patients were exploring chelation therapy, and the research would give answers about whether the treatment was safe and effective.

A similar philosophy was behind an effort to test chelation on autistic children. The government, however, recently scrapped that plan, citing safety concerns as one reason.

The heart disease study was based on misrepresentations about safety and effectiveness and ''should never have been approved,'' said Dr. Kimball Atwood, an anesthesiologist in suburban Boston and an assistant clinical professor at Tufts University.

He and several others sent a complaint about the heart study to the federal research protection agency, and recently published a lengthy report detailing alleged problems.

The largest alternative medicine study the government has ever launched has stopped enrolling people while officials investigate whether participants were fully informed of the risks and are being adequately protected, the Associated Press has learned.

Get the full article here.


Story tools

Email  Email   Print  Print   Save  Save   Reprint  Reprint   Popular  Most Popular   Reprint  Subscribe

Share this story

AddThis Social Bookmark Button
















Most Commented Stories